Cargando…

Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma

Gliomas are brain tumors characterized by an immunosuppressive microenvironment. Immunostimulatory agonistic CD40 antibodies (αCD40) are in clinical development for solid tumors, but are yet to be evaluated for glioma. Here, we demonstrate that systemic delivery of αCD40 in preclinical glioma models...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hooren, Luuk, Vaccaro, Alessandra, Ramachandran, Mohanraj, Vazaios, Konstantinos, Libard, Sylwia, van de Walle, Tiarne, Georganaki, Maria, Huang, Hua, Pietilä, Ilkka, Lau, Joey, Ulvmar, Maria H., Karlsson, Mikael C. I., Zetterling, Maria, Mangsbo, Sara M., Jakola, Asgeir S., Olsson Bontell, Thomas, Smits, Anja, Essand, Magnus, Dimberg, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257767/ https://www.ncbi.nlm.nih.gov/pubmed/34226552 http://dx.doi.org/10.1038/s41467-021-24347-7

Ejemplares similares

Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
por: van de Walle, Tiarne, et al.
Publicado: (2021)

Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer
por: Vaccaro, Alessandra, et al.
Publicado: (2023)

Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment
por: van Hooren, Luuk, et al.
Publicado: (2016)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
por: Georganaki, Maria, et al.
Publicado: (2018)

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma
por: Huang, Hua, et al.
Publicado: (2021)

Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
por: Georganaki, Maria, et al.
Publicado: (2020)

Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases
por: Zetterling, Maria, et al.
Publicado: (2017)

DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2021)

Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity
por: Roodakker, Kenney Roy, et al.
Publicado: (2018)

Preoperative Patient-Reported Outcomes in Suspected Low-Grade Glioma: Markers of Disease Severity and Correlations with Molecular Subtypes
por: Buvarp, Dongni, et al.
Publicado: (2021)

Meningioma classification by immunohistochemistry: A replicability study
por: Näslund, Olivia, et al.
Publicado: (2022)

Indications and outcome in surgically treated asymptomatic meningiomas: a single-center case-control study
por: Näslund, Olivia, et al.
Publicado: (2020)

The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas
por: Dénes, Anna, et al.
Publicado: (2023)

Diffusion Kurtosis Imaging of Gliomas Grades II and III - A Study of Perilesional Tumor Infiltration, Tumor Grades and Subtypes at Clinical Presentation
por: Delgado, Anna F., et al.
Publicado: (2017)

Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2023)

IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
por: Martikainen, Miika, et al.
Publicado: (2021)

Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
por: Wenger, Anna, et al.
Publicado: (2019)

Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2022)

Long-term follow up of patients with WHO grade 2 oligodendroglioma
por: Carstam, Louise, et al.
Publicado: (2023)

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
por: Niinivirta, Marjut, et al.
Publicado: (2020)

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study
por: Corell, Alba, et al.
Publicado: (2020)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period
por: Svenjeby, Caroline, et al.
Publicado: (2022)

Stemness and clinical features in relation to the subventricular zone in diffuse lower-grade glioma: an exploratory study
por: Corell, Alba, et al.
Publicado: (2022)

CD93 promotes β(1) integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
por: Lugano, Roberta, et al.
Publicado: (2018)

Alzheimer’s disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer’s disease
por: Libard, Sylwia, et al.
Publicado: (2019)

Classification of Adverse Events Following Surgery in Patients With Diffuse Lower-Grade Gliomas
por: Gómez Vecchio, Tomás, et al.
Publicado: (2021)

Tumor angiogenesis: causes, consequences, challenges and opportunities
por: Lugano, Roberta, et al.
Publicado: (2019)

Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade
por: Libard, Sylwia, et al.
Publicado: (2014)

Health-related quality of life and emotional well-being in patients with glioblastoma and their relatives
por: Ståhl, Pernilla, et al.
Publicado: (2020)

Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients
por: Werlenius, Katja, et al.
Publicado: (2020)

Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
por: Hillerdal, Victoria, et al.
Publicado: (2014)

Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015
por: Carstam, Louise, et al.
Publicado: (2019)

Characteristics of the tissue section that influence the staining outcome in immunohistochemistry
por: Libard, Sylwia, et al.
Publicado: (2018)

In vivo Characterization of Biochemical Variants of Amyloid-β in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease Neuropathological Change
por: Libard, Sylwia, et al.
Publicado: (2021)

Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
por: Kerzeli, Iliana K., et al.
Publicado: (2021)

Complementarity-determining region clustering may cause CAR-T cell dysfunction
por: Sarén, Tina, et al.
Publicado: (2023)

Lessons of Vascular Specialization From Secondary Lymphoid Organ Lymphatic Endothelial Cells
por: Arroz-Madeira, Silvia, et al.
Publicado: (2023)

The risk of ventricular catheter misplacement and intracerebral hemorrhage in shunt surgery for hydrocephalus
por: Hultegård, Linus, et al.
Publicado: (2015)

The influence of irrigation fluid temperature on recurrence in the evacuation of chronic subdural hematoma
por: Bartley, Andreas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h545n426np23uca31q5fl73a0i